Argenx Se (ARGX) Work In Process (2020 - 2023)
Argenx Se (ARGX) posted Work In Process of $47.1 million for Q4 2023, down 27.6% on a QoQ basis from $65.0 million in Q4 2022, and down 27.6% year-over-year from $65.0 million in Q4 2022.
Argenx Se (ARGX) Work In Process (2020 - 2023) Analysis & Trends
Argenx Se's Work In Process history runs 4 years deep, the most recent figure standing at $47.1 million for Q4 2023.
- Quarterly Work In Process fell 27.6% year-over-year to $47.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $47.1 million (down 27.6% YoY) and the FY2023 annual result came in at $47.1 million, down 27.6% from the prior year.
- Work In Process was $47.1 million for Q4 2023 at Argenx Se, down from $65.0 million in the prior quarter.
- Across five years, Work In Process topped out at $65.0 million in Q4 2022 and bottomed at $6.4 million in Q4 2020.
- A 4-year average of $39.0 million and a median of $42.4 million in 2021 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2021 — Work In Process jumped 489.12% — and 2023, when it fell 27.6%.
- Argenx Se's Work In Process stood at $6.4 million in 2020, then soared by 489.12% to $37.7 million in 2021, then soared by 72.43% to $65.0 million in 2022, then decreased by 27.6% to $47.1 million in 2023.
- Business Quant data shows ARGX's Work In Process at $47.1 million in Q4 2023, $65.0 million in Q4 2022, and $37.7 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 47.07 Mn |
| Dec 31, 2022 | 65.02 Mn |
| Dec 31, 2021 | 37.71 Mn |
| Dec 31, 2020 | 6.40 Mn |